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http://dx.doi.org/10.1016/j.stemcr.2016.09.012SUMMARYNaive and primed pluripotent stem cells (PSCs) and germ cells express theOct4 gene. TheOct4 gene contains two cis-regulatory elements,
the distal enhancer (DE) and proximal enhancer (PE), which differentially controlOct4 expression in a cell-type-specific and stage-specific
manner. Here, we generated double transgenic mice carrying both Oct4-DPE-GFP and Oct4-DDE-tdTomato (RFP), enabling us to simulta-
neously monitor the activity of DE and PE. Oct4 expression is stage-specifically regulated by DE and PE during embryonic and germ cell
development. Using this dual reporter system, we successfully cultured pure populations of naive (GFP+RFP) and primed (GFPRFP+)
PSCs. We found that GFP+RFP cells were metastable (not naive) in serum-containing medium; stable naive pluripotent cells were
observed in medium containing two inhibitors (Meki and GSKi) but lacked serum. Finally, we suggest that the activity of Oct4 DE and
PE is regulated by the repressive histone marks and DNA methylation in a cell-type-specific manner.INTRODUCTION
Pluripotent stem cells (PSCs) can self-renew unlimitedly
and have the potential to differentiate into all somatic
and germ cell types. PSCs can be derived from the inner
cell mass (ICM) of blastocyst or implanted epiblast cells
(Hanna et al., 2010; Nichols and Smith, 2009). ICM and
epiblast cells are pluripotent cells but not bona fide stem
cells in vivo, as they differentiate to eventually establish
the three germ layers in the gastrulating embryo. Both
cell populations can be grown as PSCs when they are
cultured in vitro with stem cell maintenance medium.
Interestingly, the ICM of blastocysts forms ‘‘naive’’ plurip-
otent embryonic stem cells (ESCs) and epiblast cells form
‘‘primed’’ pluripotent epiblast stem cells (EpiSCs) (Hanna
et al., 2010). Primed PSCs have limited differentiation po-
tential in vivo; they barely contribute to chimeras by blas-
tocyst injection analysis. Primed PSCs maintain stemness
through basic fibroblast growth factor (bFGF) and Activin/
Nodal signaling pathways (Brons et al., 2007; Greber
et al., 2010; Vallier et al., 2009) but not by STAT3 and
bone morphogenetic protein 4 pathways (Nichols and
Smith, 2009). These two PSCs exhibit different molecular
signatures but still share many important markers. One of
the commonly expressed genes in these cells is Oct4,
which is a PSC and germ cell marker (Scholer et al.,
1990). In addition to maintenance of PSCs, Oct4 alone
can transform differentiated cells into PSCs, referred to
as induced PSCs (iPSCs) (Kim et al., 2009). The Oct4
gene contains three distinct cis-regulatory elements: the
proximal promoter (PP), the distal enhancer (DE), and
the proximal enhancer (PE), which differentially controlStem Cell Rep
This is an open access article under the COct4 expression during embryogenesis (Yeom et al.,
1996). Although Oct4 is expressed in both naive and
primed PSCs, the regulatory mechanism of Oct4 expres-
sion differs between these cell types; Oct4 expression in
naive and primed pluripotent cells is differentially
controlled by DE and PE, respectively (Brons et al.,
2007; Tesar et al., 2007; Yeom et al., 1996). Accordingly,
enhancer activity is altered as primed PSCs are converted
into naive PSCs through the induction of extrinsic
signaling or genetic modification (Bao et al., 2009; Guo
et al., 2009; Hanna et al., 2009).
Two recent reports used the Oct4-DPE-GFP marker to
discriminate naive human PSCs from primed human
PSCs (Gafni et al., 2013; Theunissen et al., 2014). However,
as shown in flow cytometry data in Theunissen et al.
(2014), Oct4-DPE-GFP reporter activity is not completely
negative (including weak GFP activity) in primed human
ESCs. Moreover, the Oct4-DPE-GFP+ cells may still include
ESCs utilizing Oct4-PE, since a mono-transgenic system
cannot discriminate between cells using only Oct4-DE
and cells using both Oct4-PE and Oct4-DE, which may
constitute an impure population of naive PSCs. Therefore,
in this studywe established a dual reporter system for naive
and primed mouse pluripotent cells, using two fluorescent
reporters, GFP and tdTomato (RFP), controlled by the cis-
regulatory elements DE and PE, respectively. We found
that the expression of Oct4-DPE-GFP and Oct4-DDE-RFP
accurately represents the expression of naive and primed
cells during the development of double transgenic mice.
Thus, this double transgenic system can reproduce the
in vivo Oct4 regulatory system, providing a tool for study-
ing the regulation of naive and primed pluripotency andorts j Vol. 7 j 911–926 j November 8, 2016 j ª 2016 The Author(s). 911
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enabling the separation of pure populations of naive and
primed PSCs.RESULTS
Generation of Dual-Color Fluorescence Transgenic
Mice Containing Oct4-DPE-GFP and Oct4-DDE-RFP
Oct4 is expressed in both naive and primed PSCs. However,
Oct4 expression in naive and primed pluripotent cells is
differentially controlled by two regulatory elements, DE
and PE, respectively. We intended to understand how
Oct4 is regulated by DE and PE during development (Fig-
ure 1). Therefore, we generated double transgenic mice ex-
pressing GFP and RFP under the control of either DE or PE
of Oct4, respectively. O4-DE-GFP mice carried the Oct4-
DPE-GFP transgene, originally termed OG2 (Szabo et al.,
2002), and O4-PE-RFP mice carried the Oct4-DDE-RFP
transgene (Figure 1A). Five O4-PE-RFP founder transgenic
mice (two male and three female) were generated (Fig-
ure S1). O4-PE-RFP mice were crossed with homozygous
O4-DE-GFP mice, and subsequently O4-DE-GFP+//O4-
PE-RFP+/+ double transgenic mice were derived (Figure 1A).
O4-DE-GFP+//O4-PE-RFP+/ embryos were obtained from
wild-type female mice after crossing them with O4-DE-
GFP+//O4-PE-RFP+/+ male mice. All transgenic animals
that were studied for their expression had one allele of
each transgene (O4-DE-GFP+//O4-PE-RFP+/). In all trans-
genic animals both endogenous Oct4 alleles were present.O4-DE-GFP and O4-PE-RFP Recapitulate the
Stage-Specific Expression of Oct4 during Mouse
Embryo Development
Two-cell-stage embryos did not express either GFP nor RFP
(Figure 1B), in agreement with the zygotic genome not be-
ing active at this stage. GFP was initially detected in eight-
cell embryos and was strongly expressed at the ICM of the
blastocyst stage, whereas RFP was not detected even at the
blastocyst stage (Figure 1B), indicating that PE is dispens-
able for Oct4 expression in the pre-implantation embryo.
Next, we observed the expression of O4-DE-GFP and O4-
PE-RFP during the post-implantation stages (6.5–13.5 days
post coitum [dpc]). The 5.5- and 6.5-dpc epiblasts were pos-
itive both for GFP and RFP (Figures 1C and S2). At 7.25 dpc
the intensity of theGFP signal decreased, but the RFP signal
remained strong in epiblast cells (Figure 1D). Primordial
germ cells (PGCs) were not distinguishable at this stage.
However, at 8.5 dpc, GFP-positive cells were localized to
the posterior regions of the embryos where the PGCs
form a cluster and begin migrating into the genital ridge
(Figure 1E). Although RFP-positive cells were detected
extensively at the posterior regions of the embryos, these
cells did not overlap with the GFP-positive cells, indicating912 Stem Cell Reports j Vol. 7 j 911–926 j November 8, 2016that early PGCs do not require PE for Oct4 expression. At
9.5 dpc, GFP-positive cells were detected in the hindgut
area (Figure 1F). RFP-positive cells disappeared from the
soma; however, some cells in the hindgut expressed both
RFP and GFP (approximately 34.7%), indicating that
migratory PGCs at 9.5 dpc can be divided into two popula-
tions: GFP+ and GFP+/RFP+ cells. At the 10.5-dpc stage,
when getting close to the genital ridge, most PGCs ex-
pressed both Oct4-GFP and -RFP (Figure 1G). This was
also the case once the PGCs arrived at and proliferated
in the gonads (13.5 dpc; Figure 1H). These results
demonstrate that the two regulatory regions, DE and PE,
dynamically control Oct4 expression during embryonic
development and that founder PGCs use DE while migra-
tory as well as post-migratory PGCs employ both DE and
PE to drive Oct4 expression.
Oct4 has been shown to be expressed in mitotically ar-
rested prospermatogonia and type A spermatogonia, but
is downregulated in type B spermatogonia and spermato-
cytes in adult testis (Pesce et al., 1998). Expression of
both GFP and RFP was detected 7 days postpartum (dpp)
in the seminiferous tubules of male transgenic testis (Fig-
ure 1I). Interestingly, although both GFP+ and RFP+ cells
were detected in 4-week-old adult male mouse testis, only
GFP+ cells were localized to the periphery (near the base-
ment membrane) of the seminiferous tubules while RFP+
cells were detected at the center of the seminiferous tubules
(Figure 1J). Immunohistochemistry analysis confirmed
that the GFP+ cells are present at the periphery (type A sper-
matogonia niche) of the seminiferous tubules and that the
RFP+ cells are detected at the center (differentiated germ cell
niche) of the seminiferous tubules (Figure S3). These results
indicate that type A spermatogonia at the pre-meiotic divi-
sion stage (7 dpp) can use both DE and PE to express Oct4
but that in adult testis only DE drives Oct4 expression in
type A spermatogonia of 4-week-old mice. Committed
germ cells located near the lumen also express Oct4, which
is controlled by PE.
In this study, we focused on spermatogenic cells since
RFP was not detected in the transgenic ovary. We did not
detect transgenic expression in somatic cells. For example,
we detected neither a GFP nor an RFP signal in neural stem
cells (NSCs) (Figure 1K), demonstrating that our transgenic
system is specific for the germline, i.e., PSCs and germ cells,
but not for somatic stem cells. Taken together, our results
indicate that DE and PE activities stage-specifically regulate
expression ofOct4 in totipotent/pluripotent cells and germ
cells in the developing mouse embryo.
Derivation of ESCs from Dual-Color Fluorescence
Transgenic Blastocysts
Previous studies have suggested that ESCs grown under
conventional ESC culture conditions are a heterogeneous
Figure 1. Generation of Dual Transgenic Mice (O4-DE-GFP/O4-PE-RFP) and the Distinct Oct4 Regulatory Elements in the Totipotent
Cycle
(A) Physical maps of wild-type endogenous Oct4, Oct4-DPE-GFP (O4-DE-GFP), and Oct4-DDE-RFP (O4-PE-RFP).
(B) The expression pattern of O4-DE-GFP and O4-PE-RFP in pre-implantation embryos (2C, blastocyst). The O4-DE-GFP/O4-PE-RFP
pre-implantation embryos expressed only O4-DE-GFP. Scale bars, 50 mm.
(C–H) The expression pattern of O4-DE-GFP and O4-PE-RFP in post-implantation embryos. Phase and fluorescence images of (C) 6.5-dpc
embryo (scale bar, 100 mm); (D) 7.25-dpc embryo (scale bar, 100 mm); (E) 8.5-dpc embryo (scale bar, 100 mm); (F) 9.5-dpc embryo and
migrating PGCs (scale bar, 100 mm); (G) 10.5-dpc embryo and PGCs (scale bar, 100 mm); and (H) 13.5-dpc embryo and gonad (scale bar,
100 mm). Arrowheads indicate GFP-positive areas in the developing gonads.
(I and J) The expression pattern of O4-DE-GFP and O4-PE-RFP in testis. Phase and fluorescence image of (I) 7-dpp testis and seminiferous
tubules and (J) 4-week-old adult mouse testis and seminiferous tubules. Scale bars, 100 mm.
(K) The neurosphere did not express either O4-DE-GFP or O4-PE-RFP. Scale bar, 100 mm.
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population (Hayashi et al., 2008; Martinez Arias and Brick-
man, 2011; Miyanari and Torres-Padilla, 2012). Thus, we
attempted to verify the heterogeneity of ESCs and derive
a pure population of naive pluripotent ESCs, using our dou-
ble transgenic system. Blastocysts were plated on a feeder-
layered dish in conventional mouse ESC medium (serum +
leukemia inhibitory factor [LIF]) (Figures 2A and 2B).
Initially the ICM of blastocysts expressed only GFP,
whereas RFP was expressed after 3 days. As the ICM out-
growths expanded, the GFP+RFP cells became GFP+RFP+
cells (Figure 2B). This result supports a previous study
demonstrating that pluripotent ESC derivation requires
epiblast specification (Boroviak et al., 2014). This in vitro
culture system indirectly suggests that during the 4.5- to
5.5-dpc embryonic development, GFP+RFP cells may be
gradually changed into GFP+RFP+ cells in vivo. Trypsinized
ICM outgrowth cells were transferred into a new dish with
serum + LIF medium where two distinct ESC populations
were cultured (GFP+RFP and GFP+RFP+; Figure 2C). Fluo-
rescence-activated cell sorting analysis showed that during
the initial stage of ESC derivation in serum + LIF the
GFP+RFP cells, presumably naive PSCs, constituted only
72.7%, while GFP+RFP+ and GFPRFP+ cells constituted
22.1% and 0.49%, respectively, of the population (Fig-
ure 2D). When GFP+RFP cells were sorted and recultured
in serum + LIF medium, GFP+RFP cells reverted to
GFP+RFP+ subsequent to ten passages (Figure 2E). In
contrast, when GFP+RFP+ cells were sorted and cultured
in serum + LIF medium, GFP+RFP+ cells reverted to
GFP+RFP cells subsequent to ten passages (Figure 2E).
These results demonstrate that the ESCs in serum + LIF me-
diumwere heterogeneous; they contained two populations
of cell types that were interconvertible. These GFP+RFP+
and GFP+RFP cell populations could not have been distin-
guished using an Oct4-DPE-GFP mono-transgenic system.
Next, we modified the culture conditions by adding
two inhibitors (2i), ERK1/2 (PD0325901) and GSK3
(CHIR99021), into the serum + LIF medium. Previous re-
ports have demonstrated that these 2i contributed to the
establishment of naive PSCs and shielded PSCs from differ-
entiation triggers (Ying et al., 2008). Under serum + LIF + 2i
conditions, only 76.0% of cells were GFP+RFP and 23.0%
were GFP+RFP+ (Figures 2F and 2G). When the GFP+RFP
cells were sorted and cultured for ten passages under
serum + LIF + 2i conditions, 3.45% became GFP+RFP+ (Fig-
ure 2H, left panel). In contrast, the sorted GFP+RFP+ cells
also converted into GFP+RFP cells (70.1%) (Figure 2H,
right panel). These findings indicate that serum + LIF + 2i
culture conditions are insufficient for the maintenance of
GFP+RFP cells. Thus, ESCs are metastable and intercon-
vertible between GFP+RFP and GFP+RFP+ cells in serum-
containing medium. Next, we used the new culture
medium to obtain a pure population of naive PSCs. Serum914 Stem Cell Reports j Vol. 7 j 911–926 j November 8, 2016was removed from the medium since mouse ESCs ex-
hibited elevated levels of ERK1/2 phosphorylation, a key
event in priming of ESCs for differentiation (Kunath
et al., 2007; Wray et al., 2011; Yamaji et al., 2013), in
serum-containing medium. Serum-free ESC culture me-
dium (N2B27 medium) supplemented with 2i in combina-
tion with LIF (Marks et al., 2012; Silva et al., 2008; Ying
et al., 2008) was used for ESC culturing. ESCs (from serum +
LIF culture) were transferred intoN2B27 + LIF + 2imedium.
On day 2 after transfer to theN2B27 + LIF + 2imedium (Fig-
ure 2I), most GFP+RFP+ cells were converted into GFP+RFP
cells (98.9%; Figure 2J). Subsequent to further culturing,
nearly all cells were maintained as GFP+RFP cells (94.3%;
Figure 2K). Next, the ESCs (fromN2B27 + LIF + 2i medium)
were transferred into serum + LIF medium. Subsequent to
2 days of culturing, nearly all of the GFP+RFP cells were
converted into GFP+RFP+ cells (67.2%; Figure 2L). Taken
together, our double transgenic system unequivocally
shows that the ESCs in serum-containing medium were
heterogeneous. This heterogeneous ESC population
became homogeneous subsequent to culturing in serum-
free medium supplemented with 2i and LIF. Therefore,
serum-free culture condition is an essential requirement
for culturing a pure population of naive PSCs.
Distinct Gene Expression Patterns in 2i-GFP-, GFP-,
and GFP/RFP-Positive ESCs
Oct4 expression is controlled by the DE in naive PSCs,
while the PE regulates Oct4 expression in primed PSCs
(Brons et al., 2007; Tesar et al., 2007; Yeom et al., 1996).
Therefore, we investigated whether the expression of
Oct4-DPE-GFP and Oct4-DDE-RFP accurately represents
the naive and primed PSC states in an in vitro culture sys-
tem. We compared the global gene expression patterns of
GFP+RFP (fromN2B27 + LIF + 2i and serum + LIFmedium)
and GFP+RFP+ cells (from serum + LIF) using microarray
analysis (Illumina MouseRef-8 v2 Expression BeadChip).
Surprisingly, the gene expression profile of GFP+RFP cells
cultured in N2B27 + LIF + 2i (2i-GFP+RFP) was distinct
from that of GFP+RFP cells cultured in serum + LIF (Fig-
ure 3A). The hierarchical clustering and multidimensional
scaling (MDS) plot analyses showed that the gene expres-
sion pattern of GFP+RFP cells was more similar to
GFP+RFP+ cells than to 2i-GFP+RFP cells (Figures 3B and
3C). Pairwise scatter-plot analyses also demonstrated that
GFP+RFP+ cells were almost identical to GFP+RFP cells
(0.998), which were distinct from 2i-GFP+RFP cells (Fig-
ures 3D–3F). Differentially expressed genes in GFP+RFP
and GFP+RFP+ cells were largely associated with germline
development; GFP+RFP cells highly expressed Wnt3a,
Rhox5, Rhox6, Rhox9, Nanos3, and Tcfap2c (Figure 3G). We
found that 249 genes were upregulated and 446 genes
were downregulated in 2i-GFP+RFP versus GFP+RFP cells
Figure 2. ESC Culture Conditions Influence the Activity of Oct4 Enhancers
(A and B) Derivation of ESCs from O4-DE-GFP/O4-PE-RFP blastocysts. O4-PE-RFP was initially expressed during the establishment of ESCs.
Scale bars, 50 mm.
(C) Phase and fluorescence images of O4-DE-GFP/O4-PE-RFP ESCs in serum + LIF medium. Scale bars, 50 mm.
(D) Flow cytometry analysis of the proportion of O4-DE-GFP+ only cells or O4-DE-GFP+ and O4-PE-RFP+ cells in serum + LIF medium.
(E) Flow cytometry analysis of the proportion of O4-DE-GFP+ only cells or O4-DE-GFP+ and O4-PE-RFP+ cells from sorted O4-DE-GFP+ only
cells or O4-DE-GFP+ and O4-PE-RFP+ cells cultured in serum + LIF medium for ten passages.
(F) Phase and fluorescence images of O4-DE-GFP/O4-PE-RFP ESCs in serum + LIF + 2i medium. Scale bars, 50 mm.
(G) Flow cytometry analysis of the proportion of O4-DE-GFP+ only cells or O4-DE-GFP+ and O4-PE-RFP+ cells in serum + LIF + 2i medium.
(H) Flow cytometry analysis of the proportion of O4-DE-GFP+ only cells or O4-DE-GFP+ and O4-PE-RFP+ cells from sorted O4-DE-GFP+only
cells or O4-DE-GFP+ and O4-PE-RFP+ cells cultured in serum + LIF + 2i medium for ten passages.
(I) Phase and fluorescence images of O4-DE-GFP/O4-PE-RFP ESCs in N2B27 + LIF + 2i medium. Scale bars, 50 mm.
(J and K) Flow cytometry analysis of the proportion of O4-DE-GFP+ only cells or O4-DE-GFP+ and O4-PE-RFP+ cells cultured in N2B27 + LIF +
2i medium for 2 days (J) or ten passages (K).
(L) Flow cytometry analysis of the proportion of O4-DE-GFP+ only cells or O4-DE-GFP+ and O4-PE-RFP+ cells cultured in serum + LIF medium
for 2 days from N2B27 + LIF + 2i medium.
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Figure 3. 2i-GFP-Positive Cells Cultivated in N2B27 + LIF + 2i Medium and GFP- or GR-Positive Cells Cultivated in Serum + LIF
Medium Exhibit Distinct Gene Expression Patterns
(A) Heatmap of global gene expression patterns in 2i-GFP+, GFP+RFP (GFP), and GFP+RFP+ (GR) cells.
(B and C) Hierarchical clustering (B) and MDS plot (C) analysis showing that 2i-GFP-positive cells are distinct from GFP- or
GR-positive cells.
(D–F) Scatter plots of global gene expression comparing (D) 2i-GFP- and GFP-positive cells, (E) 2i-GFP- and GR-positive cells, and (F) GFP-
and GR-positive cells.
(G) Heatmap analysis shows that GFP-positive cells express germ cell-related genes including Wnt3a, Rhox5, Rhox6, Rhox9, Nanos3, and
Tcfap2c at a higher level than do GR-positive cells.
(H) Heatmap analysis showing that 2i-GFP-positive cells highly express naive pluripotency-related genes and GFP- and GR-positive cells
highly express differentiation markers.
(I) Quantitative gene expression analysis of pluripotency markers (Oct4, Nanog, Sox2, Esrrb), naive pluripotency markers (Rex1, Klf2, Klf4,
Tcl1, Tbx3, Prdm14), and differentiation markers (Dnmt1, Dnmt3a, Dnmt3b, T, Fgf5). Data are presented as mean ± SEM for n = 3 inde-
pendent experiments. GAPDH was used as a housekeeping gene.
916 Stem Cell Reports j Vol. 7 j 911–926 j November 8, 2016
(Figure S4A). The expression levels of pluripotency factors
such as Pou5f1 (Oct4), Nanog, Zfp42 (Rex1), Esrrb, Sall4,
and Lin28were almost identical in 2i-GFP+RFP, GFP+RFP,
and GFP+RFP+ cells (Figure 3H). However, the naive plurip-
otency markers, Klf4, Tcl1, and Tbx3, were more highly ex-
pressed in 2i-GFP+RFP than in GFP+RFP and GFP+RFP+
cells. In contrast, differentiation-related genes such as
Dnmt3b, Brachyury (T), Otx2, and Fgf5 were more highly
upregulated in GFP+RFP and GFP+RFP+ cells than in 2i-
GFP+RFP cells. These gene expression patterns were
further confirmed by qRT-PCR analysis (Figure 3I). The
expression levels of the pluripotencymarkers (Oct4,Nanog,
Sox2, Rex1, Esrrb, and Klf2) in 2i-GFP+RFP cells were
similar to those inGFP+RFP andGFP+RFP+ cells (Figure 3I).
However, while naive pluripotency markers were upregu-
lated in 2i-GFP+RFP cells, the development-related genes
were downregulated (Figure S4B). These findings suggest
that althoughGFP+RFP cells displaymore naive character-
istics (such as higher expression of germ cell markers) un-
der serum + LIF culture conditions, they are in ametastable
state and are readily converted into GFP+RFP+ cells. Stable
naive PSCs could be maintained only in serum-free
N2B27 + LIF + 2i medium, since 2i-GFP+RFP cells were
found to be distinct from GFP+RFP cells cultured in
serum-containingmedium and expressed a greater number
of naive pluripotency markers.
Functional annotation clustering of differentially ex-
pressed genes using gene ontology (GO) analysis revealed
that the upregulated genes (>2-fold) in 2i-GFP+RFP cells
were significantly enriched for GO terms linked to ‘‘sterol
biosynthetic and metabolic process,’’ ‘‘cholesterol biosyn-
thetic and metabolic process,’’ and ‘‘lipid biosynthetic
process’’ (Marks et al., 2012) (Table S1). The upregulated
genes in GFP+RFP or GFP+RFP+ cells were enriched for
GO terms linked to ‘‘gland, tube development, and devel-
opmental growth,’’ ‘‘collagen metabolic and catabolic
process,’’ ‘‘membrane organization,’’ and ‘‘germ cell devel-
opment’’ (Table S2).
GFPRFP+ Cells Represent Primed PSCs
The results of our study show that GFP+RFP ESCs stably
maintain a naive pluripotent state when cultured in
serum-free N2B27 + LIF + 2i medium. Next, we sought to
identify primed PSCs using the double transgenic system.
Since the PE regulates Oct4 expression in EpiSCs (Brons
et al., 2007; Tesar et al., 2007), primed PSCs must be
GFPRFP+ cells and naive PSCs must be GFP+RFP cells.
During EpiSC derivation from O4-DE-GFP+//O4-PE-
RFP+/ epiblasts, the initial expression of GFP decreased
and only RFP+ cells were expanded (Figures S5A and S5B).
Next, we tried to differentiate GFP+RFP+ ESCs into
GFPRFP+ EpiSC-like cells (EpiLCs). The GFP+RFP+ ESCs
changedmorphologically to formflat colonies that becameGFPRFP+ cells (Figure 4A). Heatmap and hierarchical clus-
tering analyses showed that the gene expression patterns of
GFPRFP+ cells were more similar to EpiSCs than to ESCs
(Figures 4B and 4C). The GFPRFP+ cells were more similar
to EpiSCs than to 2i-GFP+, GFP+RFP, or GFP+RFP+ cells by
MDS plot and scatter-plot analyses (Figures 4D–4G). These
results demonstrate that transition of enhancer activity
from DE to PE parallels the conversion from the naive to
primed pluripotent state. Next, we examined the expres-
sion of core pluripotency-, naive pluripotency-, and differ-
entiation-related genes in GFPRFP+ EpiLCs (Figure 4H).
Oct4 and Nanog were highly expressed in EpiLCs, EpiSCs,
and all ESC lines (Figure 4H). However, GFPRFP+ EpiLCs
expressed very low levels of the naive pluripotency-related
genes Klf2, Klf4, Klf5,Dppa3,Dppa4, Zfp42, Tbx3, and Tcl1,
as shown for the EpiSCs. However, the differentiation-
related genes Krt18, Fgf5, Fgf8, Otx2, T (Brachyury), and
Nestin were highly expressed in GFPRFP+ EpiLCs and
EpiSCs. qRT-PCR analysis confirmed the high expression
of the core pluripotency genes (Oct4 and Nanog) and EpiSC
markers (T and Fgf5), and low expression of Sox2, Klf2, and
Klf4 in GFPRFP+ EpiLCs and EpiSCs (Figure 4G). These
data show that GFPRFP+ EpiLCs are similar to EpiSCs in
terms of morphology and gene expression profiles.
Next, we investigated the DNAmethylation status at the
promoter regions of Nanog, Stella (Dppa3), and Dppa5 in
GFP+RFP, GFP+RFP+, 2i-GFP+RFP, and GFPRFP+ EpiLCs
(Figures 4J–4L). TheNanog promoter regions were hypome-
thylated in all samples (Figure 4J). However, the promoter
regions of Stella and Dppa5 were hypermethylated in
GFPRFP+ EpiLCs (Figures 4K and 4L). Long interspersed
nuclear element 1 (LINE1) and Intracisternal A particle (IAP)
have been shown to be hypermethylated in primed PSCs
(Yamaji et al., 2013). Thus, we examined the DNA methyl-
ation status of LINE1 and IAP in GFPRFP+ EpiLCs
compared with GFP+RFP, GFP+RFP+, and 2i-GFP+RFP
cells (Figures 4M and 4N). The LINE1 regions were more
hypermethylated in GFPRFP+ EpiLCs than in GFP+
(GFP+RFP, GFP+RFP+, and 2i-GFP+RFP) cells (Figure 4M).
The IAP regions were more methylated in RFP+ cells
(GFP+RFP+ and GFPRFP+ EpiLCs) than in GFP+RFP and
2i-GFP+RFP cells (Figure 4N). Taken together, these results
indicate that the Oct4-DPE-RFP reporter represents an
applicable primed PSC marker. Thus, the conversion of
ESCs into EpiLCs entails a shift from GFP+ to RFP+ (i.e.,
from DE to PE regulation), which also coincides with a
change in transcriptome and epigenetic status specific for
the primed pluripotent state.
Developmental Potential of GFPRFP+ Cells
The ability of chimera formation is a strict criterion that
distinguishes naive PSCs from primed PSCs (Chenoweth
et al., 2010; Nichols and Smith, 2009, 2011). NaiveStem Cell Reports j Vol. 7 j 911–926 j November 8, 2016 917
Figure 4. Oct4-DDE-RFP-Positive Cells
Constitute Primed Pluripotent Stem Cells,
as Determined by Gene Expression Pat-
terns and Epigenetic Status
(A) Phase and fluorescence images of EpiSC-
like cells (EpiLCs) from O4-DE-GFP/O4-PE-RFP
ESCs. These EpiLCs express Oct4-DDE-RFP but
not Oct4-DPE-GFP. Scale bars, 100 mm.
(B) Heatmap of global gene expression pat-
terns in 2i-GFP+, GFP+RFP (GFP+), GFP+RFP+
(GR), GFPRFP+ (RFP) cells, ESCs, EpiSCs, and
mouse embryonic fibroblasts (MEF).
(C and D) Hierarchical clustering and MDS
plot analyses showing that RFP-positive cells
are more similar to EpiSCs than to ESCs, 2i-
GFP+, GFP+, or GR+ cells.
(E–G) Scatter plots of global gene expression
comparing (E) EpiSCs and GFP-positive cells,
(F) EpiSCs and GR-positive cells, and (G)
EpiSCs and RFP-positive cells.
(H and I) Heatmap (H) and quantitative
gene expression (I) analysis show that
RFP-positive cells do not express naive plu-
ripotency-related genes but highly express
primed pluripotency-related genes. Data are
presented as mean ± SEM for n = 3 indepen-
dent experiments. GAPDH was used as a
housekeeping gene.
(J–N) Bisulfite genomic sequencing of the
Nanog (J), Stella (K), Dppa5 (L), LINE (M),
and IAP (N) regions in 2i-GFP+, GFP+, GR+, and
RFP+ cells. Black and white circles represent
methylated and unmethylated CpGs, respec-
tively.pluripotent ESCs contribute to chimeras; however, primed
pluripotent EpiSCs barely contribute to chimeric embryos
subsequent to blastocyst injection followed by transfer to918 Stem Cell Reports j Vol. 7 j 911–926 j November 8, 2016a surrogate mother (Brons et al., 2007). GFP+RFP and
GFP+RFP+ cells as well as GFPRFP+ EpiLCs were aggregated
with wild-type eight-cell embryos and further cultured
Figure 5. In Vivo Development Potential
of Oct4-DDE-RFP-Positive Cells
(A) Aggregation of GFP-, GR-, and RFP-pos-
itive cells with normal embryo. RFP-positive
cells did not incorporate into the embryos.
Scale bars, 50 mm.
(B) Aggregation efficiency of GFP-, GR-, and
RFP-positive cells.until the blastocyst stage. The GFP+RFP and GFP+RFP+
cells were efficiently incorporated into the ICM of blasto-
cysts (Figures 5A and 5B). Interestingly, at day 1 post aggre-
gation, incorporated GFP+RFP cells co-expressed RFP,
similar to GFP+RFP+ cells (Figure 5A). The aggregation
efficiency of GFP+RFP and GFP+RFP+ cells was indistin-
guishable at 91.1% (41/45) and 93.3% (42/45), respectively
(Figure 5B). However, basically all GFPRFP+ EpiLCs failed
to incorporate into the ICM of blastocysts, the aggregation
efficiency being 0% (0/27) (Figures 5A and 5B). These re-
sults indicate that GFP+ cells exhibit characteristics of naive
pluripotency and GFPRFP+ EpiLCs demonstrate those of
primed pluripotency-like EpiSCs.
Control of the DE and PE Elements in Naive
and Primed PSCs
The activity of the Oct4 enhancers in naive and primed
PSCs was evaluated in luciferase assays showing that 2i-
GFP+ cells mainly use DE for Oct4 expression while PE
was completely inactive; PE is slightly active in the control
of ESCs cultured in serum + LIF medium (Figure 6A).
GFP+RFP and GFP+RFP+ cells in serum + LIF medium
also mainly used DE, but the activity of PE was higherthan in 2i-GFP+ cells. In contrast, the GFPRFP+ cells
mainly utilized PE for Oct4 expression, similar to EpiSCs
and P19 embryonic carcinoma cells (Figure 6A). These re-
sults confirm that the expression of Oct4-DPE-GFP and
Oct4-DDE-RFP accurately represents the naive and primed
PSC state; thus, the double transgenic reporter system can
be used as a tool for purifying populations of naive
(2i-GFP+ cells) and primed (GFPRFP+ cells) PSCs, since
the regulatory mechanisms underlying the two different
pluripotent states can be precisely defined.
Recent studies have shown that histone modifications
are closely associated with the activity of enhancers
(Creyghton et al., 2010; Favaedi et al., 2012). Acetylation
of histoneH3 lysine 27 (H3K27) is an indicator of active en-
hancers (Bonn et al., 2012), and deacetylation of H3K27 is
associated with decreased gene expression or poised en-
hancers. H3K27me3 and H3K9me3 have also been sug-
gested to be poised enhancer marks (Creyghton et al.,
2010; Favaedi et al., 2012). H3K9me3 can distinguish
poised from active enhancers independently of
H3K27me3 (Zentner et al., 2011). Thus, we investigated
the chromatin enrichment state of H3K27ac, H3K27me3,
and H3K9me3 in 2i-GFP+, GFP+RFP, GFP+RFP+, andStem Cell Reports j Vol. 7 j 911–926 j November 8, 2016 919
Figure 6. Epigenetic Status of Oct4 Regulatory Elements in Naive and Primed Pluripotent Stem Cells
(A) Analysis of Oct4 enhancer activity in ESCs, 2i-GFP+ cells, GFP+ GR+ cells, RFP+ cells, EpiSCs, and P19 embryonic carcinoma cells. Relative
luciferase activity was normalized to the activity of the empty vector. Data are presented as mean ± SEM for n = 3 independent experi-
ments.
(B) ChIP-qPCR analysis to determine immunoglobulin G (IgG), H3K27ac, H3K27me3, and H3K9me3 enrichment on the Oct4 distal and
proximal enhancers. Data are presented as mean ± SEM for n = 3 independent experiments. Coloured stars indicate histone tails, such as
H3K9 and H3K27.
(C) ChIP-qPCR analysis to determine IgG and Nanog enrichment on the Oct4 distal and proximal enhancers. Data are presented as mean ±
SEM for n = 3 independent experiments.
(D) Bisulfite genomic sequencing of the regions of the Oct4 DE, PE, and PP in 2i-GFP+, GFP+, GR+, and RFP+ cells, and MEF. Black and white
circles represent methylated and unmethylated CpGs, respectively.
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GFPRFP+ cells (Figure 6B) using chromatin immunopre-
cipitation (ChIP)-qPCR analysis. The results of the ChIP-
qPCR analysis showed that H3K27ac was highly enriched
on the DE and PE of Oct4 in all Oct4-expressing cells, naive
(2i-GFP+), metastable (GFP+RFP and GFP+RFP+), and
primed (GFPRFP+) PSCs (Figure 6B). The poised enhancer
marks H3K27me3 and H3K9me3 were enriched on PE
rather than on DE in 2i-GFP+ cells. The level of
H3K27me3 on the PE was slightly higher than that on DE
in metastable cells (GFP+RFP and GFP+RFP+), but the level
of H3K9me3 on the DE and PE did not differ significantly.
Therefore, in the metastable state, epigenetic marks
seem to fluctuate and the activity of PE and DE cannot be
distinguished by histone marks. In primed pluripotent
GFPRFP+ cells, H3K9me3 was enriched on DE rather
than on PE while the level of H3K27me3 was not different.
These results suggest that enrichment of H3K9me3 and
H3K27me3 on PE indicates the naive pluripotent state
and that enrichment of H3K9me3 on DEmarks the primed
pluripotent state.
Transcription factors can regulate Oct4 expression by
binding to DE and PE (Wu and Scholer, 2014). Galonska
et al. (2015) showed that 2i condition alters the binding
enrichment of Nanog on PE in ESCs. Thus we next checked
the binding profiles of Nanog on PE and DE of Oct4 in
different cell populations. ChIP-qPCR analysis showed
that Nanog was highly enriched on the DE rather than
on PE in 2i-GFP+ cells, naive PSCs (Figure 6C). On the other
hand, Nanog was more enriched on the PE in GFP+RFP
and GFP+RFP+ cells. These results suggest that the differen-
tial activity of DE and PE is closely related to binding
affinity of transcription factors.
Since both DNA methylation and histone modification
regulate gene expression and affect each other (Cedar and
Bergman, 2009), we next examined the DNA methylation
pattern of the Oct4 regulatory elements. The DNA methyl-
ation status of DE, PE, and PP of Oct4 were analyzed by
bisulfite DNA sequencing analysis (Figure 6D). The DE,
PE, and PP of Oct4 in naive PSCs (2i-GFP+), GFP+RFP,
and GFP+RFP+ cells were completely unmethylated. How-
ever, primed PSCs (GFPRFP+) showed relatively hyperme-
thylated patterns in the DE of Oct4, indicating that the DE
of Oct4 in primed PSCs is regulated by DNAmethylation as
well as H3K9me3 (Figures 6B–6D).DISCUSSION
In this study, we show that DE and PE coordinately regulate
Oct4 expression during embryonic and germ cell develop-
ment in vivo and naive and primed pluripotency in vitro.
The cell-specific and temporal control of DE and PE could
be precisely determined using the dual reporter system.Approximately two decades ago, we first determined the ac-
tivity of the genomic fragment containing Oct4 using a
b-galactosidase reporter and found that DE activity was
ESC- and germ cell-specific and that PE was epiblast- and
embryonic carcinoma cell (P19)-specific (Yeom et al.,
1996). Oct4-GFP transgenic mice have been generated
and used for the detection of PGCs and PSCs and for moni-
toring reprogramming through nuclear transfer, cell
fusion, and the transduction of reprogramming factors
(Boiani et al., 2002; Choi et al., 2014; Do and Scho¨ler,
2004). However, these existing transgenic systems cannot
concurrently discriminate between the activity of DE and
PE. In this study, a developed dual reporter system allowed
us to monitor the DE, PE, and DE + PE activity
simultaneously.
Enhancers play a central role in cell-type-specific and
stage-specific regulation of gene expression and are
capable of acting over a distance ranging from several to
hundreds, and in rare cases even thousands of kilobases
from their target genes (Bulger and Groudine, 2011; Ong
and Corces, 2011, 2012). In developing mouse embryos,
Oct4 gene expression is regulated spatially and temporally
by at least two enhancers, DE and PE (Yeom et al., 1996).
Here we have elucidated the control of Oct4 expression
by its DE and PE elements during the totipotent cycle (Fig-
ure 7A). The Oct4 gene is expressed under the control of
the DE during the pre-implantation stage, but its expres-
sion is controlled by PE in the epiblast subsequent to im-
plantation (Figure 7A; Scholer, 1991). Expression of the
Oct4 gene is downregulated in epiblasts and expressed
exclusively in the developing germline. In founder PGCs,
Oct4 is initially controlled by DE but subsequently by
both DE and PE (Figures 1E–1J and 7A). Interestingly, we
found that Oct4 was expressed not only in spermatogonia
but also in differentiating germ cells; in adult mice, Oct4
expression was regulated by DE in spermatogonia but by
PE in differentiating germ cells. It is well known that
PGCs first emerge at the proximal region of the epiblast
adjacent to the extraembryonic ectoderm and then
migrate to form the PGC cluster at 7.25 dpc (Ginsburg
et al., 1990; Saitou et al., 2002). However, while our dual
reporter system could not distinguish the PGC population
at 7.25 dpc, Oct4-DPE-GFP PGCs were apparent in 8.5-dpc
embryos. Intriguingly, migrating PGCs in 9.5- and
10.5-dpc embryos contained two subpopulations,
GFP+RFP and GFP+RFP+ cells, and the GFP+RFP+ cell pop-
ulation increased during PGC migration into the genital
ridge. Since genome-wide epigenetic modification,
including imprinting erasure, occurs in migrating PGCs
(Sasaki and Matsui, 2008), further experiments are
required to examine the differences between these two
migrating PGC populations and whether they can be
distinguished using genome-wide epigenetic markers.Stem Cell Reports j Vol. 7 j 911–926 j November 8, 2016 921
Figure 7. Schematic Representation of the
Oct4 Regulatory Elements
(A) The regulatory element of Oct4 during the
totipotent cycle.
(B) Epigenetic status of the Oct4 enhancer in
naive and primed pluripotency.This study showed that ICM cells initially express only
GFP but express both GFP and RFP during the derivation
of ESCs (Figure 2B). This result supports the findings of
recent studies indicating that the ability of ICM cells to
self-renew as ESCs is acquired during epiblast specification
(Boroviak et al., 2014; Tang et al., 2010). Boroviak et al.
(2014) also suggested that early ICM cells are distinct
from ESCs and that ESCs exhibit the greatest degree of
identity to the embryonic day 4.5 (E4.5) epiblast. Our re-
sults confirm that the switch in enhancer activity occurs
at approximately the E4.5 stage (Yeom et al., 1996), and922 Stem Cell Reports j Vol. 7 j 911–926 j November 8, 2016enhancer activity ofDE and PE overlapped in early post-im-
plantation epiblast (5.5–6.5 dpc).
Self-renewing ESCs cultivated in conventional ESC cul-
ture medium (supplemented with LIF and serum) consti-
tute a cell population at various stages of pluripotency
(Hayashi et al., 2008; Martinez Arias and Brickman, 2011;
Miyanari and Torres-Padilla, 2012). A defined ESC culture
system, containing 2i (MEK inhibitor PD0325901 and
glycogen synthase kinase 3 inhibitor CHIR99021) (Ying
et al., 2008) together with LIF (2i + LIF) has been used to
select naive pluripotent cells (Silva et al., 2008). Here we
show that ESCs from 2i + LIF medium still contain two cell
populations when cultured in serum-containing medium
and that the mixed population could be converted to ho-
mogeneous naive PSCs by using serum-free N2B27 me-
dium. This result indicates that serum contains a factor(s)
that induce differentiation or inhibit maintenance of naive
pluripotency. Previous reports have suggested that serum
contains ERK phosphorylation-inducing factors (Yamaji
et al., 2013). Silva et al. (2008) also showed that the
presence of MEK inhibitor in serum-containing medium
accelerated the activation ofNanog and Rex1 during reprog-
ramming. This is also supported by the findings that
GFP+RFP ESCs cultured in serum-containing medium
were molecularly distinguishable from GFP+RFP ESCs
cultured in serum-freemedium. Collectively, theGFP+RFP
state is a necessary but not sufficient condition for naive
PSCs, since specialmedium is also required formaintaining
naive PSCs. Several reporter systems suggested that undif-
ferentiated ESCs heterogeneously expressed Nanog (Cham-
bers et al., 2007), Rex1 (Marks et al., 2012; Toyooka et al.,
2008), Stella (Hayashi et al., 2008), Esrrb (van den Berg
et al., 2008), and Tbx3 (Niwa et al., 2009). The heterogene-
ity of transcription factors in ESCs regulated self-renewal
capacity, expression of developmental genes, and differen-
tiation potential (Torres-Padilla and Chambers, 2014).
However, the GFP+RFP and GFP+RFP+ ESCs in serum-
containing medium are similar to each other at the tran-
scriptional, epigenetic, and functional levels. Our dual
transgenic system allows monitoring of enhancer activity
of DE and PE, but not Oct4 expression levels. Although
enhancer activity fluctuates between GFP+RFP and
GFP+RFP+ in serum-containing medium, these cells highly
expressed Oct4 gene.
Mixed populations of PSCs were also converted to naive
PSCs in 2i + LIF medium without serum or to primed
EpiLCs in bFGF + activin medium. EpiLCs induced from
ESCs expressed only RFP, and the RFP+ EpiLCs were indis-
tinguishable from EpiSCs in terms of morphology, gene
expression patterns, epigenetic status, and defective incor-
poration into ICM of blastocysts. Therefore, GFPRFP+
state constitute a definitive marker of primed PSCs;
GFPRFP+ cells were not observed in any of the three
different ESC culture media.
The conversion from GFP+RFP+ to GFP+RFP cells and
vice versa takes place within 2 days of changing the culture
medium (Figure 2), indicating that the conversion of
enhancer activity occurs within 2 days. It has been sug-
gested that genome-wide demethylation and transcrip-
tional changes occur in mouse ESCs within the first 24 hr
of 2i addition (Ficz et al., 2013). Therefore, the regulatory
machinery of Oct4 enhancers seems to change rapidly in
response to external cues accompanying epigenetic
modification.GFPRFP+ EpiLCs derived from transgenic ESCs showed
the molecular signature of EpiSCs, including expression of
EpiSC markers and hypermethylation of germ cell markers
(Stella and Dppa5 region), LINE1, and IAP. Primed PSCs are
derived from post-implantation stage epiblasts and express
Oct4 for self-renewal under the control of the PE (Brons
et al., 2007; Tesar et al., 2007). RFP+ cells were not incorpo-
rated into the ICM by aggregation with normal embryos.
Although a single aggregated embryo with RFP+ cells was
observed, the GFPRFP+ cells did not contribute to the ICM
(Figure S6). This result could support the observation that
GFPRFP+ cells formed a pure population of primed PSCs.
Finally, we showed that the activity of the twoOct4 cis-reg-
ulatory elements was controlled by DNA methylation and
histone modification concurring with the naive or primed
pluripotency state. Consequently, the differential activity
ofDE and PEwas closely related to binding affinity ofNanog
on the twoenhancers;Nanogwashighly enrichedon theDE
innaive PSCs, but highly enriched on the PE in primed PSCs
(Figures 6C and 7B). We also found that the activity of Oct4
DE and PE is affected by the repressive histone marks,
H3K9me3 and H3K27me3, and DNA methylation in a cell-
type-specific manner. The enhancers of Oct4 in primed
PSCs is regulated by DNA methylation as well as H3K9me3,
but those in naive PSCs is regulated by H3K9me3 and
H3K27me3 but not by DNAmethylation; DNAmethylation
was only correlatedwith inactiveDE inprimedPSCs andnot
with inactive PE in naive PSCs (Figure 7B). Thus, demethyla-
tion of the PE region seems to be the default state for PSCs
and methylation of DE could constitute an epigenetic
marker for primed PSCs. In contrast, H3K27ac was enriched
in both the DE and PE of naive and primed PSCs, indicating
thatH3K27ac cannotbe ahistonemark for the active state of
the Oct4 DE and PE. Another explanation is that although
one of the enhancers is not active based on fluorescent re-
porter expression, epigenetically these enhancer elements
of Oct4 are basically not completely silenced as H3K27ac re-
mains enriched inbothnaive andprimedPSCs. Similarly the
PE is notmethylated in 2i/LIF conditions, although the fluo-
rescentmark isnoton.These results suggest thatoverall both
enhancers are active and never fully silenced in any of the
states, although their level of activity is different under the
tested conditions. Thus we should be more careful against
using of terms ‘‘off’’ and ‘‘on’’ when describing enhancer
activity of Oct4, the more accurate term rather being ‘‘domi-
nant activity.’’ This fact could also be the reason for the need
of a dual reporter system for accurate separation of naive and
primed PSCs.
In this study, we showed that enhancer-specific regula-
tion ofOct4 could constitute a determinant for distinguish-
ing between naive and primed pluripotency. This is based
on the ability to accurately separate naive and primed
PSCs using the dual reporter system, thereby obtainingStem Cell Reports j Vol. 7 j 911–926 j November 8, 2016 923
pure populations of naive and primed pluripotent cells,
which could be used for accurate analysis of distinct cell
states. The dual reporter system could also be a useful
tool for monitoring cellular reprogramming to naive or
primed states as well as embryonic development under
live-cell conditions.EXPERIMENTAL PROCEDURES
Generation of O4-DE-GFP/O4-PE-RFP Mouse
To generate the Oct4-DDE-RFP transgene, we inserted the
tdTomato (RFP) gene into genomic Oct4 fragments of 6 kb in
length (GOF6), which lack DE (Yeom et al., 1996). Oct4-DDE-RFP
transgene expresses tdTomato transgene under the control of
Oct4 PE and PP. O4-PE-RFP embryos were generated by injecting
Oct4-DDE-RFP (O4-PE-RFP) plasmid into normal zygote, which
were developed to blastocysts. O4-PE-RFP blastocysts were trans-
ferred into the uterus of a pseudo-pregnant female mouse. We first
generated five O4-PE-RFP founder transgenic mice, two male and
three female (Figure S1). OG2 mice were purchased from the
Jackson Laboratory and maintained in the mouse facility, and
used for O4-DE-GFP founder mice (Szabo et al., 2002). The
O4-PE-RFP mouse was crossed with homozygous O4-DE-GFP
mouse. Finally, we generated O4-DE-GFP+/ O4-PE-RFP+/ mice
carrying both Oct4-DPE-GFP and Oct4-DDE-RFP.
ESC Derivation and Culture
ESC lines from blastocyst were derived essentially as described pre-
viously (Nichols et al., 2009). Embryos at the eight-cell stage were
flushed from oviducts of C57/BL6 mice mated with male O4-DE-
GFP/O4-PE-RFP mice at 2.5 dpc, cultured in G2 medium for
2 days, and transferred to conventional ESC medium with 15%
fetal bovine serum (FBS), 13 penicillin/streptomycin/glutamine,
0.1 mM nonessential amino acids, 1 mM b-mercaptoethanol,
and 103 units/mL LIF on feeder layers. The established ESCs in
conventional ESC medium were transferred into conventional
ESC medium supplemented with LIF and 2i inhibitors,
CHIR99021(3 mM) and PD0325901 (1 mM), or serum-free N2B27
medium supplemented with LIF and 2i inhibitors. The serum-
free N2B27 was prepared as described by Ying and Smith (2003).
EpiSCs-like Cell Differentiation from ESCs
EpiLCs from ESCs were derived essentially as described previously
(Hayashi et al., 2011). The EpiLCs were induced by plating 1.0 3
105 ESCs on a well of a 12-well plate on a feeder layer or feeder
free in N2B27 medium containing activin A (20 ng/mL), bFGF
(12 ng/mL), and knockout serum replacement (1%). The medium
was changed every day. The differentiated EpiLCs (Oct4-DDE-RFP-
positive cells) were passaged every 2–3 days by dissociation with
1 mg/mL collagenase type IV (Invitrogen) or by pipetting with a
glass pipette.
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